Dare Bioscience Inc.
DARE | NASDAQ
$0.87
+$0.06 (+7.41%)
Sep 22, 2026, 2:00 PM ET · Market open
Market Data
Market Cap $12.13M
Enterprise Value $533.95K
Beta 1.01
Average Volume 559.01K
Shares Outstanding (Diluted) 14.89M
Shares Change YoY 67.85%
Institutional Ownership 7.06%
Exchange NASDAQ
ISIN US23666P2002
Price Performance
Price Change 1M -1.2%
Price Change 3M -60.9%
Price Change 6M -42.1%
Price Change YTD -58.5%
Price Change 1Y -60.3%
Price Change 3Y -85.3%
Price Change 5Y -96.1%
1M CAGR (ann.) -42.1%
1Y CAGR (ann.) -61.1%
5Y CAGR (ann.) -47.4%
All-Time CAGR -42.6%
Valuation
PE Ratio -1.03
Forward PE 0.17
PEG Ratio -0.01
Forward PEG 0.02
PS Ratio 8.88
Forward PS 1.40
PB Ratio -21.66
P/FCF Ratio -1.03
P/Adj. FCF Ratio -0.92
P/OCF Ratio -1.07
EV/Sales 0.39
EV/EBIT -0.05
EV/EBITDA -0.06
EV/FCF -0.05
Earnings Yield -97.5%
FCF Yield -96.9%
Adj. FCF Yield -109.3%
Financial Health
Net Cash $11.6M
Total Debt $1.02M
Cash & Short-Term Investments $12.62M
Total Assets $22.37M
Current Ratio 0.99
Quick Ratio 0.99
Debt / Equity Ratio -12.08
Debt / EBITDA -0.11
Debt / FCF -0.09
OCF / Debt -11.10
Interest Coverage -55.72
Altman Z-Score -13.40
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -89.5%
Operating Profit Margin -813.4%
EBITDA Margin -672.6%
Net Profit Margin -804.4%
FCF Margin -860.6%
Adj. FCF Margin -970.6%
SBC / Revenue 110.0%
SBC Impact (per share) -12.8%
Returns
Return on Assets -49.1%
Return on Equity -748.1%
Return on Invested Capital -179.1%
Return on Capital Employed -203.9%
Return on Tangible Assets -49.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -52.8%
Revenue CAGR 5Y -60.9%
Revenue CAGR 10Y 10.5%
EPS CAGR 3Y 10.5%
EPS CAGR 5Y 32.1%
EPS CAGR 10Y 28.6%
FCF CAGR 3Y -3.4%
FCF CAGR 5Y 25.9%
FCF CAGR 10Y 1.3%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y 97.0%
Revenue Growth Next 3Y 325.9%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.14
EPS Growth Est (next Q) -50.0%
Revenue Est (next Q) $2.02M
Revenue Growth Est (next Q) 89127.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1
Price Target Upside 23.5%
Cash Flow
Operating Cash Flow $-11.29M
Free Cash Flow $-11.76M
Adj. Free Cash Flow $-13.26M
FCF Per Share -$0.79
OCF Per Share -$0.76
OCF/S Ratio -826.8%
Income Statement
Revenue $1.37M
Gross Profit $-1.22M
Operating Income $-11.11M
EBITDA $-9.19M
Net Income $-10.99M
EPS (Diluted) -$0.79
Revenue / Employee $59.39K
Profit / Employee $-477.7K
Employees 23
Add to Watchlist
Select watchlists to add or remove DARE